Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy

• Asıl Yazarlar: Jordan D. Lewicky (Yazar), Alexandrine L. Martel (Yazar), Nya L. Fraleigh (Yazar), Emilie Picard (Yazar), Leila Mousavifar (Yazar), Arnaldo Nakamura (Yazar), Francisco Diaz-Mitoma (Yazar), René Roy (Yazar), Hoang-Thanh Le (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Perhaps the greatest limitation for the continually advancing developments in cancer immunotherapy remains the immunosuppressive tumor microenvironment (TME). The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) axis is an emerging immunotherapy target, with the resulting type I...